Study: Insulin Pump Better Than Injections
Study: Insulin Pump Better Than Injections
Researchers Say 'Artificial Pancreas' for Type 1 Diabetes May Be Reality in Several Years
But in an interview with WebMD, Wolpert called the insulin pump-sensor device an important step forward in diabetes management for the right patient.
"This technology really does bring diabetes self-management to the next level," he says. "But patients really do need to be pretty skilled in using the information provided by the sensor effectively."
The next generation of pumps that both monitor and deliver insulin automatically are poised to simplify diabetes management. But Wolpert says patient education will still be a critical component of controlling the disease, Wolpert says.
Francine Kaufman, MD, who is vice president of global medical affairs for Medtronic, tells WebMD the company recently began studies in the U.S. of a pump-sensor device that will automatically stop delivering insulin if blood sugar drops too low.
The company is already marketing such a device in Europe, and she says the goal is to win FDA approval in the U.S. within the next several years.
Study: Insulin Pump Better Than Injections
Researchers Say 'Artificial Pancreas' for Type 1 Diabetes May Be Reality in Several Years
Motivated Patients Had Best Outcomes continued...
But in an interview with WebMD, Wolpert called the insulin pump-sensor device an important step forward in diabetes management for the right patient.
"This technology really does bring diabetes self-management to the next level," he says. "But patients really do need to be pretty skilled in using the information provided by the sensor effectively."
The next generation of pumps that both monitor and deliver insulin automatically are poised to simplify diabetes management. But Wolpert says patient education will still be a critical component of controlling the disease, Wolpert says.
Francine Kaufman, MD, who is vice president of global medical affairs for Medtronic, tells WebMD the company recently began studies in the U.S. of a pump-sensor device that will automatically stop delivering insulin if blood sugar drops too low.
The company is already marketing such a device in Europe, and she says the goal is to win FDA approval in the U.S. within the next several years.
Source...